CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors

Over half of breast-cancer-related deaths are due to recurrence 5 or more years after initial diagnosis and treatment. This latency suggests that a population of residual tumor cells can survive treatment and persist in a dormant state for many years. The role of the microenvironment in regulating t...

Descripción completa

Detalles Bibliográficos
Autores principales: Walens, Andrea, DiMarco, Ashley V, Lupo, Ryan, Kroger, Benjamin R, Damrauer, Jeffrey S, Alvarez, James V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478432/
https://www.ncbi.nlm.nih.gov/pubmed/30990165
http://dx.doi.org/10.7554/eLife.43653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478432/
https://www.ncbi.nlm.nih.gov/pubmed/30990165
http://dx.doi.org/10.7554/eLife.43653

Ejemplares similares